{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:31:19Z","timestamp":1794047479811,"version":"4.8.0"},"reference-count":15,"publisher":"Ferrata Storti Foundation (Haematologica)","issue":"2","license":[{"start":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T00:00:00Z","timestamp":1727308800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["haematol"],"DOI":"10.3324\/haematol.2024.285966","type":"journal-article","created":{"date-parts":[[2024,9,26]],"date-time":"2024-09-26T15:40:47Z","timestamp":1727365247000},"page":"514-519","source":"Crossref","is-referenced-by-count":1,"title":["BET inhibitors downregulate the expression of the essential lncRNA &lt;i&gt;SMILO&lt;\/i&gt; in multiple myeloma through regulation of the transcription factor FLI1"],"prefix":"10.3324","volume":"110","author":[{"given":"Nahia","family":"G\u00f3mez-Echarte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edurne San","family":"Jos\u00e9-En\u00e9riz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arantxa","family":"Carrasco-Le\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naroa","family":"Barrena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leire","family":"Garate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Garc\u00eda-Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Alonso-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naroa","family":"Gimenez-Camino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estibaliz","family":"Urizar-Compains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danel","family":"Olaverri-Mendizabal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Aguirre-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Be\u00f1at","family":"Ariceta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis-Esteban","family":"Tamariz-Amador","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Rodriguez-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisco J.","family":"Planes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Belver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Ignacio","family":"Mart\u00edn-Subero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Prosper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xabier","family":"Agirre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1856","published-online":{"date-parts":[[2024,9,26]]},"reference":[{"key":"72475","doi-asserted-by":"crossref","unstructured":"Lov\u00e9n J, Hoke HA, Lin CY. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013; 153(2):320-334.","DOI":"10.1016\/j.cell.2013.03.036"},{"key":"72476","doi-asserted-by":"crossref","unstructured":"Delmore JE, Issa GC, Lemieux ME. BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell. 2011; 146(6):904-917.","DOI":"10.1016\/j.cell.2011.08.017"},{"key":"72477","doi-asserted-by":"crossref","unstructured":"Borck PC, Guo L-W, Plutzky J. BET Epigenetic reader proteins in cardiovascular transcriptional programs. Circ Res. 2020; 126(9):1190-1208.","DOI":"10.1161\/CIRCRESAHA.120.315929"},{"key":"72478","doi-asserted-by":"crossref","unstructured":"Schwalm MP, Knapp S. BET bromodomain inhibitors. Curr Opin Chem Biol. 2022; 68:102148.","DOI":"10.1016\/j.cbpa.2022.102148"},{"key":"72479","doi-asserted-by":"crossref","unstructured":"Ordo\u00f1ez R, Kulis M, Russi\u00f1ol N. Chromatin activation as a unifying principle underlying pathogenic mechanisms in multiple myeloma. Genome Res. 2020; 30(9):1217-1227.","DOI":"10.1101\/gr.265520.120"},{"key":"72480","doi-asserted-by":"crossref","unstructured":"Carrasco-Leon A, Ezponda T, Meydan C. Characterization of complete lncRNAs transcriptome reveals the functional and clinical impact of lncRNAs in multiple myeloma. Leukemia. 2021; 35(5):1438-1450.","DOI":"10.1038\/s41375-021-01147-y"},{"key":"72481","doi-asserted-by":"crossref","unstructured":"Welsh SJ, Barwick BG, Meermeier EW. Transcriptional heterogeneity overcomes disrupting drug combinations in multiple myeloma. Blood Cancer Discov. 2024; 5(1):34-55.","DOI":"10.1158\/2643-3230.BCD-23-0062"},{"key":"72482","doi-asserted-by":"crossref","unstructured":"Handa H, Honma K, Oda T. Long noncoding RNA PTV1 Is regulated by bromodomain protein BRD4 in multiple myeloma and is associated with disease progression. Int J Mol Sci. 2020; 21(19):7121.","DOI":"10.3390\/ijms21197121"},{"key":"72483","doi-asserted-by":"crossref","unstructured":"Carrasco-Le\u00f3n A, Amundarain A, G\u00f3mez-Echarte N, Pr\u00f3sper F, Agirre X. The Role of lncRNAs in the pathobiology and clinical behavior of multiple myeloma. Cancers (Basel). 2021; 13(8):1976.","DOI":"10.3390\/cancers13081976"},{"key":"72484","doi-asserted-by":"crossref","unstructured":"Belver L, Yang AY, Albero R. Gata3-controlled nucleosome eviction drives Myc enhancer activity in T-cell development and leukemia. Cancer Discov. 2019; 9(12):1774-1791.","DOI":"10.1158\/2159-8290.CD-19-0471"},{"key":"72485","doi-asserted-by":"crossref","unstructured":"Li Y, Luo H, Liu T, Zacksenhaus E, Ben-David Y. The ets transcription factor Fli-1 in development, cancer and disease. Oncogene. 2015; 34(16):2022-2031.","DOI":"10.1038\/onc.2014.162"},{"key":"72486","doi-asserted-by":"crossref","unstructured":"Stockley J, Morgan N V, Bem D. Enrichment of FLI1 and RUNX1 mutations in families with excessive bleeding and platelet dense granule secretion defects. Blood. 2013; 122(25):4090-4093.","DOI":"10.1182\/blood-2013-06-506873"},{"key":"72487","doi-asserted-by":"crossref","unstructured":"Amundarain A, Valc\u00e1rcel L V, Ordo\u00f1ez R. Landscape and clinical significance of long noncoding RNAs involved in multiple myeloma expressed fusion transcripts. Am J Hematol. 2022; 97(3):E113-E117.","DOI":"10.1002\/ajh.26450"},{"key":"72488","doi-asserted-by":"crossref","unstructured":"Roe J-S, Mercan F, Rivera K, Pappin DJ, Vakoc CR. BET bromodomain inhibition suppresses the functional output of hematopoietic transcription factors in acute myeloid leukemia. Mol Cell. 2015; 58(6):1028-1039.","DOI":"10.1016\/j.molcel.2015.04.011"},{"key":"72489","doi-asserted-by":"crossref","unstructured":"Song J, Yuan C, Yang J. Novel flavagline-like compounds with potent Fli-1 inhibitory activity suppress diverse types of leukemia. FEBS J. 2018; 285(24):4631-4645.","DOI":"10.1111\/febs.14690"}],"container-title":["Haematologica"],"original-title":[],"link":[{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285966\/77546","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/haematol.2024.285966\/78050","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/haematologica.org\/article\/download\/11766\/77546","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T10:07:19Z","timestamp":1794046039000},"score":1,"resource":{"primary":{"URL":"https:\/\/haematologica.org\/article\/view\/haematol.2024.285966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,26]]},"references-count":15,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2025,2,1]]}},"URL":"https:\/\/doi.org\/10.3324\/haematol.2024.285966","relation":{},"ISSN":["1592-8721","0390-6078"],"issn-type":[{"value":"1592-8721","type":"electronic"},{"value":"0390-6078","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,26]]}}}